Skip to main content
Top
Published in: Journal of Clinical Immunology 2/2022

01-02-2022 | Pneumonia | Original Article

Neonatal Manifestations of Chronic Granulomatous Disease: MAS/HLH and Necrotizing Pneumonia as Unusual Phenotypes and Review of the Literature

Authors: Antonio Marzollo, Francesca Conti, Linda Rossini, Beatrice Rivalta, Lucia Leonardi, Caterina Tretti, Francesca Tosato, Maria Chiriaco, Giorgiana Madalina Ursu, Cristina Tea Natalucci, Maddalena Martella, Alessandro Borghesi, Cecilia Mancini, Andrea Ciolfi, Gigliola di Matteo, Marco Tartaglia, Caterina Cancrini, Andrea Dotta, Alessandra Biffi, Andrea Finocchi, Silvia Bresolin

Published in: Journal of Clinical Immunology | Issue 2/2022

Login to get access

Abstract

Chronic granulomatous disease (CGD) is a rare inborn error of immunity (IEI), characterized by a deficient phagocyte killing due to the inability of NADPH oxidase to produce reactive oxygen species in the phagosome. Patients with CGD suffer from severe and recurrent infections and chronic inflammatory disorders. Onset of CGD has been rarely reported in neonates and only as single case reports or small case series. We report here the cases of three newborns from two different kindreds, presenting with novel infectious and inflammatory phenotypes associated with CGD. A girl with CYBA deficiency presented with necrotizing pneumonia, requiring a prolonged antibiotic treatment and resulting in fibrotic pulmonary changes. From the second kindred, the first of two brothers developed a fatal Burkholderia multivorans sepsis and died at 24 days of life. His younger brother had a diagnosis of CYBB deficiency and presented with Macrophage Activation Syndrome/Hemophagocytic Lympho-Histiocytosis (MAS/HLH) without any infection, that could be controlled with steroids. We further report the findings of a review of the literature and show that the spectrum of microorganisms causing infections in neonates with CGD is similar to that of older patients, but the clinical manifestations are more diverse, especially those related to the inflammatory syndromes. Our findings extend the spectrum of the clinical presentation of CGD to include unusual neonatal phenotypes. The recognition of the very early, potentially life-threatening manifestations of CGD is crucial for a prompt diagnosis, improvement of survival and reduction of the risk of long-term sequelae.
Appendix
Available only for authorised users
Literature
2.
go back to reference Thomas DC, Charbonnier LM, Schejtman A, Aldhekri H, Coomber EL, Dufficy ER, et al. EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease. J Allergy Clin Immunol. 2019;143:782-785.e1.PubMed Thomas DC, Charbonnier LM, Schejtman A, Aldhekri H, Coomber EL, Dufficy ER, et al. EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease. J Allergy Clin Immunol. 2019;143:782-785.e1.PubMed
3.
go back to reference Prince BT, Thielen BK, Williams KW, Kellner ES, Arnold DE, Cosme-Blanco W, et al. Geographic Variability and Pathogen-Specific Considerations in the Diagnosis and Management of Chronic Granulomatous Disease. Pediatr Heal Med Ther [Internet]. 2020;11:257–68. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32801991 Prince BT, Thielen BK, Williams KW, Kellner ES, Arnold DE, Cosme-Blanco W, et al. Geographic Variability and Pathogen-Specific Considerations in the Diagnosis and Management of Chronic Granulomatous Disease. Pediatr Heal Med Ther [Internet]. 2020;11:257–68. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​32801991
5.
go back to reference Magnani A, Mahlaoui N. Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease. Pediatr Drugs Springer International Publishing. 2016;18:335–45. Magnani A, Mahlaoui N. Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease. Pediatr Drugs Springer International Publishing. 2016;18:335–45.
6.
go back to reference Chiriaco M, Salfa I, Di Matteo G, Rossi P, Finocchi A. Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects. Pediatr Allergy Immunol. 2016;27:242–53.PubMed Chiriaco M, Salfa I, Di Matteo G, Rossi P, Finocchi A. Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects. Pediatr Allergy Immunol. 2016;27:242–53.PubMed
7.
go back to reference Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60:1176–83.PubMed Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60:1176–83.PubMed
8.
go back to reference Conti F, Lugo-Reyes SO, Blancas Galicia L, He J, Aksu G, Borges de Oliveira E, et al. J Allergy Clin Immunol. 2016;138(241):248.e3. Conti F, Lugo-Reyes SO, Blancas Galicia L, He J, Aksu G, Borges de Oliveira E, et al. J Allergy Clin Immunol. 2016;138(241):248.e3.
9.
10.
go back to reference Laskey HL, Gopal L, Gallin JI, Holland SM, Heller T. Twenty-Year Follow-Up of Esophageal Involvement in Chronic Granulomatous Disease. Am J Gastroenterol. 2009;104:2368–70.PubMedPubMedCentral Laskey HL, Gopal L, Gallin JI, Holland SM, Heller T. Twenty-Year Follow-Up of Esophageal Involvement in Chronic Granulomatous Disease. Am J Gastroenterol. 2009;104:2368–70.PubMedPubMedCentral
11.
go back to reference Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, Anaya-O’Brien S, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114(462):8. Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, Anaya-O’Brien S, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114(462):8.
12.
go back to reference Rosenzweig SD. Inflammatory manifestations in chronic granulomatous disease (CGD). J Clin Immunol. 2008;28:67–72. Rosenzweig SD. Inflammatory manifestations in chronic granulomatous disease (CGD). J Clin Immunol. 2008;28:67–72.
14.
go back to reference Álvarez-Cardona A, Rodríguez-Lozano AL, Blancas-Galicia L, Rivas-Larrauri FE, Yamazaki-Nakashimada MA. Intravenous Immunoglobulin Treatment for Macrophage Activation Syndrome Complicating Chronic Granulomatous Disease. J Clin Immunol. 2012;32:207–11.PubMed Álvarez-Cardona A, Rodríguez-Lozano AL, Blancas-Galicia L, Rivas-Larrauri FE, Yamazaki-Nakashimada MA. Intravenous Immunoglobulin Treatment for Macrophage Activation Syndrome Complicating Chronic Granulomatous Disease. J Clin Immunol. 2012;32:207–11.PubMed
15.
go back to reference Wei A, Ma H, Zhang L, Li Z, Zhang Q, Wang D, et al. Hemophagocytic lymphohistiocytosis resulting from a cytokine storm triggered by septicemia in a child with chronic granuloma disease: a case report and literature review. BMC Pediatr BMC Pediatrics. 2020;20:100.PubMed Wei A, Ma H, Zhang L, Li Z, Zhang Q, Wang D, et al. Hemophagocytic lymphohistiocytosis resulting from a cytokine storm triggered by septicemia in a child with chronic granuloma disease: a case report and literature review. BMC Pediatr BMC Pediatrics. 2020;20:100.PubMed
16.
go back to reference van den Berg JM, van Koppen E, Åhlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: The European experience. PLoS ONE. 2009;4:1–10. van den Berg JM, van Koppen E, Åhlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: The European experience. PLoS ONE. 2009;4:1–10.
17.
go back to reference Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: An Italian multicenter study. Clin Immunol. 2008;126:155–64.PubMed Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: An Italian multicenter study. Clin Immunol. 2008;126:155–64.PubMed
18.
go back to reference Hasui TSGOPD. Chronic granulomatous disease in Japan: Incidence and natural history. Pediatr Int. 1999;41(589):93. Hasui TSGOPD. Chronic granulomatous disease in Japan: Incidence and natural history. Pediatr Int. 1999;41(589):93.
19.
go back to reference Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, et al. Residual NADPH oxidase and survival in chronic granulomatous disease douglas. N Engl J Med. 2010;363:2600–10.PubMedPubMedCentral Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, et al. Residual NADPH oxidase and survival in chronic granulomatous disease douglas. N Engl J Med. 2010;363:2600–10.PubMedPubMedCentral
20.
go back to reference Åhlin A, Boer M, Roos D, Leusen J, Smith C, Sundin U, et al. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr. 1995;84:1386–94.PubMed Åhlin A, Boer M, Roos D, Leusen J, Smith C, Sundin U, et al. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr. 1995;84:1386–94.PubMed
21.
go back to reference Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic Granulomatous Disease: Report on a National Registry of 368 Patients. Medicine (Baltimore). 2000;79:155–69. Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic Granulomatous Disease: Report on a National Registry of 368 Patients. Medicine (Baltimore). 2000;79:155–69.
22.
go back to reference Liese J, Kloos S, Jendrossek V, Petropoulou T, Wintergerst U, Notheis G, et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr. 2000;137:687–93.PubMed Liese J, Kloos S, Jendrossek V, Petropoulou T, Wintergerst U, Notheis G, et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr. 2000;137:687–93.PubMed
23.
go back to reference Marzollo A, Maestrini G, La Starza R, Elia L, Malfona F, Pierini T, et al. A novel germline variant in PIK3R1 results in SHORT syndrome associated with TAL/LMO T-cell Acute Lymphoblastic Leukaemia. Am J Hematol. 2020;95(12):E335–8.PubMed Marzollo A, Maestrini G, La Starza R, Elia L, Malfona F, Pierini T, et al. A novel germline variant in PIK3R1 results in SHORT syndrome associated with TAL/LMO T-cell Acute Lymphoblastic Leukaemia. Am J Hematol. 2020;95(12):E335–8.PubMed
24.
go back to reference Motta M, Pannone L, Pantaleoni F, Bocchinfuso G, Radio FC, Cecchetti S, et al. Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum. Am J Hum Genet. 2020;107:499–513.PubMedPubMedCentral Motta M, Pannone L, Pantaleoni F, Bocchinfuso G, Radio FC, Cecchetti S, et al. Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum. Am J Hum Genet. 2020;107:499–513.PubMedPubMedCentral
25.
go back to reference Lin Y-C, Niceta M, Muto V, Vona B, Pagnamenta AT, Maroofian R, et al. SCUBE3 loss-of-function causes a recognizable recessive developmental disorder due to defective bone morphogenetic protein signaling. Am J Hum Genet. 2021;108:115–33.PubMed Lin Y-C, Niceta M, Muto V, Vona B, Pagnamenta AT, Maroofian R, et al. SCUBE3 loss-of-function causes a recognizable recessive developmental disorder due to defective bone morphogenetic protein signaling. Am J Hum Genet. 2021;108:115–33.PubMed
26.
go back to reference Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy- Moonshine A, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinforma. 2013;43:11.10.1-11.10.33. Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy- Moonshine A, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinforma. 2013;43:11.10.1-11.10.33.
27.
go back to reference Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–60.PubMedPubMedCentral Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–60.PubMedPubMedCentral
29.
go back to reference Liu X, Jian X, Boerwinkle E. dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations. Hum Mutat. 2013;34:E2393-402.PubMedPubMedCentral Liu X, Jian X, Boerwinkle E. dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations. Hum Mutat. 2013;34:E2393-402.PubMedPubMedCentral
31.
go back to reference Jagadeesh KA, Wenger AM, Berger MJ, Guturu H, Stenson PD, Cooper DN, et al. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. Nat Genet. 2016;48:1581–6.PubMed Jagadeesh KA, Wenger AM, Berger MJ, Guturu H, Stenson PD, Cooper DN, et al. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. Nat Genet. 2016;48:1581–6.PubMed
32.
go back to reference Li Q, Wang K. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. Am J Hum Genet. 2017;100:267–80.PubMedPubMedCentral Li Q, Wang K. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. Am J Hum Genet. 2017;100:267–80.PubMedPubMedCentral
34.
go back to reference Roos D, Kuhns DB, Maddalena A, Bustamante J, Kannengiesser C, de Boer M, et al. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis. 2010;44(291):9. Roos D, Kuhns DB, Maddalena A, Bustamante J, Kannengiesser C, de Boer M, et al. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis. 2010;44(291):9.
35.
go back to reference Ehl S, Astigarraga I, von Bahr GT, Hines M, Horne AC, Ishii E, et al. Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society. J Allergy Clin Immunol Pract. 2018;6:1508–17.PubMed Ehl S, Astigarraga I, von Bahr GT, Hines M, Horne AC, Ishii E, et al. Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society. J Allergy Clin Immunol Pract. 2018;6:1508–17.PubMed
36.
go back to reference Hill HR, Augustine NH, Pryor RJ, Reed GH, Bagnato JD, Tebo AE, et al. Rapid genetic analysis of X-linked chronic granulomatous disease by high-resolution melting. J Mol Diagnostics. 2010;12(368):76. Hill HR, Augustine NH, Pryor RJ, Reed GH, Bagnato JD, Tebo AE, et al. Rapid genetic analysis of X-linked chronic granulomatous disease by high-resolution melting. J Mol Diagnostics. 2010;12(368):76.
37.
go back to reference Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. 2010;45(246):65. Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. 2010;45(246):65.
38.
go back to reference Lazarus GM, Neu HC. Agents responsible for infection in chronic granulomatous disease of childhood. J Pediatr. 1975;86(415):7. Lazarus GM, Neu HC. Agents responsible for infection in chronic granulomatous disease of childhood. J Pediatr. 1975;86(415):7.
39.
go back to reference Davoodi P, Wright SA, Brown EV, Perry JR. Rare diagnosis in a neonate who presents with fever. Clin Pediatr (Phila). 2015;54:91–3. Davoodi P, Wright SA, Brown EV, Perry JR. Rare diagnosis in a neonate who presents with fever. Clin Pediatr (Phila). 2015;54:91–3.
41.
go back to reference Shigemura T, Nakazawa Y, Yoshikawa K, Hirabayashi K, Saito S, Kobayashi N, et al. Successful cord blood transplantation after repeated transfusions of unmobilized neutrophils in addition to antifungal treatment in an infant with chronic granulomatous disease complicated by invasive pulmonary aspergillosis. Transfusion. 2014;54(516):21. Shigemura T, Nakazawa Y, Yoshikawa K, Hirabayashi K, Saito S, Kobayashi N, et al. Successful cord blood transplantation after repeated transfusions of unmobilized neutrophils in addition to antifungal treatment in an infant with chronic granulomatous disease complicated by invasive pulmonary aspergillosis. Transfusion. 2014;54(516):21.
42.
go back to reference Gonzalez LA, Kiff JE, Umetsu DT. A three-week-old infant with invasive pulmonary aspergillosis. Ann Allergy. 1994;73(392):400. Gonzalez LA, Kiff JE, Umetsu DT. A three-week-old infant with invasive pulmonary aspergillosis. Ann Allergy. 1994;73(392):400.
44.
go back to reference Herman TE, Siegel MJ. Chronic granulomatous disease of childhood: neonatal serratia, hepatic abscesses, and pulmonary aspergillosis. J Perinatol. 2002;22(255):6. Herman TE, Siegel MJ. Chronic granulomatous disease of childhood: neonatal serratia, hepatic abscesses, and pulmonary aspergillosis. J Perinatol. 2002;22(255):6.
45.
go back to reference Salfa I, Cantarutti N, Angelino G, Di Matteo G, Capo V, Farinelli G, et al. Serratia marcescens osteomyelitis in a newborn with chronic granulomatous disease. Pediatr Infect Dis J. 2013;32:926.PubMed Salfa I, Cantarutti N, Angelino G, Di Matteo G, Capo V, Farinelli G, et al. Serratia marcescens osteomyelitis in a newborn with chronic granulomatous disease. Pediatr Infect Dis J. 2013;32:926.PubMed
46.
go back to reference McElroy JA, Monahan SH, Williams JV. A female neonate presenting with fever and rash. Clin Pediatr (Phila). 2011;50(779):81. McElroy JA, Monahan SH, Williams JV. A female neonate presenting with fever and rash. Clin Pediatr (Phila). 2011;50(779):81.
49.
go back to reference Johnston HC, Shigeoka AO, Hurley DC, Pysher TJ. Nocardia pneumonia in a neonate with chronic granulomatous disease. Pediatr Infect Dis J. 1989;8(526):8. Johnston HC, Shigeoka AO, Hurley DC, Pysher TJ. Nocardia pneumonia in a neonate with chronic granulomatous disease. Pediatr Infect Dis J. 1989;8(526):8.
51.
go back to reference Afrough R, Mohseni SS, Sagheb S. An Uncommon Feature of Chronic Granulomatous Disease in a Neonate. Case Rep Infect Dis. 2016;2016:1–4. Afrough R, Mohseni SS, Sagheb S. An Uncommon Feature of Chronic Granulomatous Disease in a Neonate. Case Rep Infect Dis. 2016;2016:1–4.
52.
go back to reference Narchi H, Gammoh S, Azimi P, Grossman M. Multiple nodular pneumonitis in a three-week-old female infant. Pediatr Infect Dis J. 1999;18:1–6. Narchi H, Gammoh S, Azimi P, Grossman M. Multiple nodular pneumonitis in a three-week-old female infant. Pediatr Infect Dis J. 1999;18:1–6.
53.
go back to reference Armanian A-M, Iravani P, Mohammadizadeh M, Rahimi H. Multifocal abscess in a neonate: Neonatal chronic Granulomatous disease. Case report SEAJCRR. 2014;856:67. Armanian A-M, Iravani P, Mohammadizadeh M, Rahimi H. Multifocal abscess in a neonate: Neonatal chronic Granulomatous disease. Case report SEAJCRR. 2014;856:67.
54.
go back to reference Gray PEA, Bock V, Ziegler DS, Wargon O. Neonatal Sweet Syndrome: A potential marker of serious systemic illness. Pediatrics. 2012;129(5):e1353-9.PubMed Gray PEA, Bock V, Ziegler DS, Wargon O. Neonatal Sweet Syndrome: A potential marker of serious systemic illness. Pediatrics. 2012;129(5):e1353-9.PubMed
55.
go back to reference Labrosse R, Abou-Diab J, Blincoe A, Cros G, Luu TM, Deslandres C, et al. Very early-onset inflammatory manifestations of X-Linked chronic granulomatous disease. Front Immunol. 2017;8:1–7. Labrosse R, Abou-Diab J, Blincoe A, Cros G, Luu TM, Deslandres C, et al. Very early-onset inflammatory manifestations of X-Linked chronic granulomatous disease. Front Immunol. 2017;8:1–7.
56.
go back to reference Miladinovic M, Wittekindt B, Fischer S, Gradhand E, Kunzmann S, Zimmermann SY, et al. Case Report: Symptomatic Chronic Granulomatous Disease in the Newborn. Front Immunol. 2021;12:663883.PubMedPubMedCentral Miladinovic M, Wittekindt B, Fischer S, Gradhand E, Kunzmann S, Zimmermann SY, et al. Case Report: Symptomatic Chronic Granulomatous Disease in the Newborn. Front Immunol. 2021;12:663883.PubMedPubMedCentral
58.
go back to reference Lee AH, Shannon CP, Amenyogbe N, Bennike TB, Diray-Arce J, Idoko OT, et al. Dynamic molecular changes during the first week of human life follow a robust developmental trajectory. Nat Commun. 2019;10:1092.PubMedPubMedCentral Lee AH, Shannon CP, Amenyogbe N, Bennike TB, Diray-Arce J, Idoko OT, et al. Dynamic molecular changes during the first week of human life follow a robust developmental trajectory. Nat Commun. 2019;10:1092.PubMedPubMedCentral
61.
go back to reference Bertulli C, Marzollo A, Doria M, Di Cesare S, La Scola C, Mencarelli F, et al. Expanding Phenotype of Schimke Immuno-Osseous Dysplasia: Congenital Anomalies of the Kidneys and of the Urinary Tract and Alteration of NK Cells. Int J Mol Sci. 2020;21:8604.PubMedCentral Bertulli C, Marzollo A, Doria M, Di Cesare S, La Scola C, Mencarelli F, et al. Expanding Phenotype of Schimke Immuno-Osseous Dysplasia: Congenital Anomalies of the Kidneys and of the Urinary Tract and Alteration of NK Cells. Int J Mol Sci. 2020;21:8604.PubMedCentral
63.
go back to reference Michev A, Borghesi A, Tretti C, Martella M, Di Comite A, Biffi A, et al. Neonatal-Onset Familial Mediterranean Fever in an Infant with Human Parainfluenza Virus-4 Infection. Neonatology. 2021;118(3):359–63.PubMed Michev A, Borghesi A, Tretti C, Martella M, Di Comite A, Biffi A, et al. Neonatal-Onset Familial Mediterranean Fever in an Infant with Human Parainfluenza Virus-4 Infection. Neonatology. 2021;118(3):359–63.PubMed
67.
go back to reference Sawicki GS, Lu FL, Valim C, Cleveland RH, Colin AA. Necrotising pneumonia is an increasingly detected complication of pneumonia in children. Eur Respir J. 2008;31(6):1285–91. Sawicki GS, Lu FL, Valim C, Cleveland RH, Colin AA. Necrotising pneumonia is an increasingly detected complication of pneumonia in children. Eur Respir J. 2008;31(6):1285–91.
68.
go back to reference Hoppe PA, Holzhauer S, Lala B, Bührer C, Gratopp A, Hanitsch LG, et al. Severe infections of Panton-Valentine leukocidin positive Staphylococcus aureus in children. Med (United States). 2019;98:1–7. Hoppe PA, Holzhauer S, Lala B, Bührer C, Gratopp A, Hanitsch LG, et al. Severe infections of Panton-Valentine leukocidin positive Staphylococcus aureus in children. Med (United States). 2019;98:1–7.
69.
go back to reference Viel-Thériault I, Saban J, Lewis A, Bariciak E, Grynspan D. A Case of Fulminant Bacillus cereus Lung Necrosis in a Preterm Neonate. Pediatr Dev Pathol. 2019;22:461–4.PubMed Viel-Thériault I, Saban J, Lewis A, Bariciak E, Grynspan D. A Case of Fulminant Bacillus cereus Lung Necrosis in a Preterm Neonate. Pediatr Dev Pathol. 2019;22:461–4.PubMed
70.
go back to reference Valentine G, Thomas TA, Nguyen T, Lai YC. Chronic granulomatous disease presenting as hemophagocytic lymphohistiocytosis: A case report. Pediatrics. 2014;134:e1727–30.PubMed Valentine G, Thomas TA, Nguyen T, Lai YC. Chronic granulomatous disease presenting as hemophagocytic lymphohistiocytosis: A case report. Pediatrics. 2014;134:e1727–30.PubMed
71.
go back to reference Parekh C, Hofstra T, Church JA, Coates TD. Hemophagocytic lymphohistiocytosis in children with chronic granulomatous disease. Pediatr Blood Cancer. 2011;56:460–2.PubMed Parekh C, Hofstra T, Church JA, Coates TD. Hemophagocytic lymphohistiocytosis in children with chronic granulomatous disease. Pediatr Blood Cancer. 2011;56:460–2.PubMed
72.
go back to reference Urriola N, Williams A, Keat K. Macrophage activation syndrome/haemophagocytic lymphohistiocytosis secondary to Burkholderia cepacia complex septicaemia in an elderly female carrier of X-linked chronic granulomatous disease with extreme lyonisation: ‘cepacia syndrome’ revisited. BMJ Case Rep. 2019;12:e230434.PubMedPubMedCentral Urriola N, Williams A, Keat K. Macrophage activation syndrome/haemophagocytic lymphohistiocytosis secondary to Burkholderia cepacia complex septicaemia in an elderly female carrier of X-linked chronic granulomatous disease with extreme lyonisation: ‘cepacia syndrome’ revisited. BMJ Case Rep. 2019;12:e230434.PubMedPubMedCentral
73.
go back to reference van Montfrans JM, Rudd E, van de Corput L, Henter J-I, Nikkels P, Wulffraat N, et al. Fatal hemophagocytic lymphohistiocytosis in X-linked chronic granulomatous disease associated with a perforin gene variant. Pediatr Blood Cancer. 2009;52:527–9.PubMed van Montfrans JM, Rudd E, van de Corput L, Henter J-I, Nikkels P, Wulffraat N, et al. Fatal hemophagocytic lymphohistiocytosis in X-linked chronic granulomatous disease associated with a perforin gene variant. Pediatr Blood Cancer. 2009;52:527–9.PubMed
74.
go back to reference Hisano M, Sugawara K, Tatsuzawa O, Kitagawa M, Murashima A, Yamaguchi K. Bacteria-associated haemophagocytic syndrome and septic pulmonary embolism caused by Burkholderia cepacia complex in a woman with chronic granulomatous disease. J Med Microbiol. 2007;56:702–5.PubMed Hisano M, Sugawara K, Tatsuzawa O, Kitagawa M, Murashima A, Yamaguchi K. Bacteria-associated haemophagocytic syndrome and septic pulmonary embolism caused by Burkholderia cepacia complex in a woman with chronic granulomatous disease. J Med Microbiol. 2007;56:702–5.PubMed
75.
go back to reference Akagi K, Kawai T, Watanabe N, Yokoyama M, Arai K, Harayama S, et al. A Case of Macrophage Activation Syndrome Developing in a Patient With Chronic Granulomatous Disease-associated Colitis. J Pediatr Hematol Oncol. 2014;36:e169–72.PubMed Akagi K, Kawai T, Watanabe N, Yokoyama M, Arai K, Harayama S, et al. A Case of Macrophage Activation Syndrome Developing in a Patient With Chronic Granulomatous Disease-associated Colitis. J Pediatr Hematol Oncol. 2014;36:e169–72.PubMed
76.
go back to reference Sirinavin S, Techasaensiri C, Pakakasama S, Vorachit M, Pornkul R, Wacharasin R. Hemophagocytic Syndrome and Burkholderia cepacia Splenic Microabscesses in a Child With Chronic Granulomatous Disease. Pediatr Infect Dis J. 2004;23:882–4.PubMed Sirinavin S, Techasaensiri C, Pakakasama S, Vorachit M, Pornkul R, Wacharasin R. Hemophagocytic Syndrome and Burkholderia cepacia Splenic Microabscesses in a Child With Chronic Granulomatous Disease. Pediatr Infect Dis J. 2004;23:882–4.PubMed
77.
go back to reference Maignan M, Verdant C, Bouvet GF, Van Spall M, Berthiaume Y. Undiagnosed Chronic Granulomatous Disease, Burkholderia cepacia complex Pneumonia, and Acquired Hemophagocytic Lymphohistiocytosis: A Deadly Association. Case Rep Pulmonol. 2013;2013:1–5. Maignan M, Verdant C, Bouvet GF, Van Spall M, Berthiaume Y. Undiagnosed Chronic Granulomatous Disease, Burkholderia cepacia complex Pneumonia, and Acquired Hemophagocytic Lymphohistiocytosis: A Deadly Association. Case Rep Pulmonol. 2013;2013:1–5.
78.
go back to reference Heeg M, Ammann S, Klemann C, Panning M, Falcone V, Hengel H, et al. Is an infectious trigger always required for primary hemophagocytic lymphohistiocytosis? Lessons from in utero and neonatal disease. Pediatr Blood Cancer. 2018;65:e27344.PubMedPubMedCentral Heeg M, Ammann S, Klemann C, Panning M, Falcone V, Hengel H, et al. Is an infectious trigger always required for primary hemophagocytic lymphohistiocytosis? Lessons from in utero and neonatal disease. Pediatr Blood Cancer. 2018;65:e27344.PubMedPubMedCentral
80.
go back to reference Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol. 2010;22:561–6.PubMedPubMedCentral Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol. 2010;22:561–6.PubMedPubMedCentral
81.
go back to reference Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol. 2003;15:587–90.PubMed Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol. 2003;15:587–90.PubMed
82.
go back to reference Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, et al. Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborat. Arthritis Rheumatol. 2016;68:566–76.PubMed Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, et al. Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborat. Arthritis Rheumatol. 2016;68:566–76.PubMed
84.
go back to reference Walther MM, Malech H, Berman A, Choyke P, Venzon DJ, Linehan WM, et al. The urological manifestations of chronic granulomatous disease. J Urol. 1992;147(1314):8. Walther MM, Malech H, Berman A, Choyke P, Venzon DJ, Linehan WM, et al. The urological manifestations of chronic granulomatous disease. J Urol. 1992;147(1314):8.
85.
go back to reference Rawat A, Singh S, Suri D, Gupta A, Saikia B, Minz RW, et al. Chronic granulomatous disease: two decades of experience from a tertiary care centre in North West India. J Clin Immunol. 2014;34(58):67. Rawat A, Singh S, Suri D, Gupta A, Saikia B, Minz RW, et al. Chronic granulomatous disease: two decades of experience from a tertiary care centre in North West India. J Clin Immunol. 2014;34(58):67.
86.
go back to reference Hou L, Niu W-T, Ji H-Y, Hu X-F, Fang F, Ying Y-Q. Serum Biomarkers for Early Diagnosis of Chinese X-CGD Children: Case Reports and a Literature Review. Curr Med Sci. 2019;39(343):8. Hou L, Niu W-T, Ji H-Y, Hu X-F, Fang F, Ying Y-Q. Serum Biomarkers for Early Diagnosis of Chinese X-CGD Children: Case Reports and a Literature Review. Curr Med Sci. 2019;39(343):8.
88.
go back to reference Cannioto Z, Berti I, Martelossi S, Bruno I, Giurici N, Crovella S, et al. IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur J Pediatr. 2009;168(149):55. Cannioto Z, Berti I, Martelossi S, Bruno I, Giurici N, Crovella S, et al. IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur J Pediatr. 2009;168(149):55.
89.
go back to reference Boonyawat B, Suksawat Y, Pacharn P, Suwanpakdee P, Traivaree C. X-Linked Chronic Granulomatous Disease: Initial Presentation with Intracranial Hemorrhage from Vitamin K Deficiency in Infant. Case Rep Pediatr. 2018;2018:7041204.PubMedPubMedCentral Boonyawat B, Suksawat Y, Pacharn P, Suwanpakdee P, Traivaree C. X-Linked Chronic Granulomatous Disease: Initial Presentation with Intracranial Hemorrhage from Vitamin K Deficiency in Infant. Case Rep Pediatr. 2018;2018:7041204.PubMedPubMedCentral
Metadata
Title
Neonatal Manifestations of Chronic Granulomatous Disease: MAS/HLH and Necrotizing Pneumonia as Unusual Phenotypes and Review of the Literature
Authors
Antonio Marzollo
Francesca Conti
Linda Rossini
Beatrice Rivalta
Lucia Leonardi
Caterina Tretti
Francesca Tosato
Maria Chiriaco
Giorgiana Madalina Ursu
Cristina Tea Natalucci
Maddalena Martella
Alessandro Borghesi
Cecilia Mancini
Andrea Ciolfi
Gigliola di Matteo
Marco Tartaglia
Caterina Cancrini
Andrea Dotta
Alessandra Biffi
Andrea Finocchi
Silvia Bresolin
Publication date
01-02-2022
Publisher
Springer US
Keyword
Pneumonia
Published in
Journal of Clinical Immunology / Issue 2/2022
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-021-01159-4

Other articles of this Issue 2/2022

Journal of Clinical Immunology 2/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.